Home / Pertuzumab and Trastuzumab / Canada
CA ATC L01FY01 · updated 2 Nov 2026
Pertuzumab and Trastuzumab shortage in Canada
Is there a Pertuzumab and Trastuzumab shortage in Canada?
Yes. As of 2 Nov 2026, 1 Pertuzumab and Trastuzumab product is reported short in Canada. The company estimate for the return is 30 Nov 2026. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | PERJETA-HERCEPTIN (1 vial of 420 mg/ 14 mL Vial (Perjeta) + 1 vial of 440 mg Vial (Herceptin)") discontinuation | HOFFMANN-LA ROCHE LIMITED | not given | 30 Nov 2026 | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.